Lindus Health Secures $55 Million in Series B Funding
Deal News | Jan 24, 2025 | Goodwin
Lindus Health has successfully secured $55 million in its Series B funding round to bolster its offerings in integrated clinical trial management services and proprietary trial management technology. This funding round was led by Balderton Capital with significant participation from Creandum, Firstminute, Seedcamp, and Visionaries Club, indicating strong investor confidence in Lindus Health’s business model and growth potential. Goodwin's Cambridge Technology and Life Sciences team, including Elizabeth Rhodes and Ciara Kendall, provided legal counsel to Lindus Health for this transaction. The infusion of capital is expected to enhance Lindus Health's capabilities in managing clinical trials, leveraging technology to improve efficiency and integration within the pharmaceutical and healthcare sectors.
Sectors
- Life Sciences
- Technology
- Investment & Advisory
Geography
- United Kingdom – Lindus Health is advised by the Cambridge team of Goodwin, indicating its operations are based in the UK.
- Europe – The investors, including Balderton Capital and Creandum, are European firms, highlighting the geographical influence of the region.
Industry
- Life Sciences – Lindus Health operates in the Life Sciences sector, providing clinical trial management services, crucial for the development of pharmaceuticals and medical technologies.
- Technology – The company's focus on in-house trial management technology aligns it with the Technology sector, particularly in health tech innovation.
- Investment & Advisory – Involvement of multiple investors and advisory firms indicates activity in the Investment & Advisory industry, pivotal for successful fundraising and financial strategy.
Financials
- $55 Million – The amount raised by Lindus Health in its Series B funding round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Lindus Health | Target Company | Company | A company providing integrated clinical trial management services and technology. |
| Balderton Capital | Lead Investor | Company | A leading venture capital firm that led Lindus Health's Series B funding round. |
| Creandum | Investor | Company | A venture capital firm that participated in Lindus Health's Series B round. |
| Firstminute | Investor | Company | A venture capital firm contributing to Lindus Health's Series B funding. |
| Seedcamp | Investor | Company | An early-stage venture fund backing Lindus Health in their latest round. |
| Visionaries Club | Investor | Company | A micro VC fund investing in Lindus Health's expansion through the Series B round. |
| Goodwin | Legal Advisor | Company | The legal advisory firm that assisted Lindus Health in their Series B round. |
| Elizabeth Rhodes | Legal Advisor | Person | A member of the Goodwin team advising Lindus Health. |
| Ciara Kendall | Legal Advisor | Person | A member of the Goodwin team advising Lindus Health. |